We are live on ! Find out more
II

Inspire Investing Portfolio holdings

AUM $1.71B
1-Year Est. Return 31.76%
This Fund
S&P 500
This Quarter Est. Return
+5.48%
1 Year Est. Return
+31.76%
3 Year Est. Return
+77.15%
5 Year Est. Return
+100.59%
10 Year Est. Return
AUM
$1.71B
AUM Growth
+$602M
Cap. Flow
+$595M
Cap. Flow %
34.71%
Top 10 Hldgs %
17.69%
Holding
1,178
New
70
Increased
713
Reduced
229
Closed
70

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$74.6M
2
HD icon
Home Depot
HD
+$16.9M
3
PLTR icon
Palantir
PLTR
+$14M
4
CAT icon
Caterpillar
CAT
+$12.5M
5
APH icon
Amphenol
APH
+$9.94M

Sector Composition

Rank Sector Weight
1 Technology 24.8%
2 Industrials 19.67%
3 Financials 9.24%
4 Real Estate 7.93%
5 Healthcare 6.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OTTR icon
1051
Otter Tail
OTTR
$3.87B
$128 ﹤0.01%
1
EMB icon
1052
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
$73 ﹤0.01%
1
GIL icon
1053
Gildan
GIL
$9.18B
$65 ﹤0.01%
1
-1,459
-100% -$94.3K
ACGL icon
1054
Arch Capital
ACGL
$35B
$64 ﹤0.01%
1
ASRT
1055
DELISTED
Assertio
ASRT
$59 ﹤0.01%
3
+1
+50% +$12
MGNX icon
1056
MacroGenics
MGNX
$255M
$51 ﹤0.01%
18
+4
+29% +$9
RUM icon
1057
RUM Group Inc
RUM
$1.65B
$51 ﹤0.01%
10
ZNTL icon
1058
Zentalis Pharmaceuticals
ZNTL
$317M
$50 ﹤0.01%
21
+5
+31% +$13
NKTR icon
1059
Nektar Therapeutics
NKTR
$2.34B
$48 ﹤0.01%
+1
New +$57
INGN icon
1060
Inogen
INGN
$171M
$46 ﹤0.01%
8
OPENW
1061
Opendoor Technologies Inc Series K Warrants
OPENW
$11.6M
$43 ﹤0.01%
72
IOVA icon
1062
Iovance Biotherapeutics
IOVA
$2.29B
$39 ﹤0.01%
11
GRAL
1063
GRAIL Inc
GRAL
$3.02B
$39 ﹤0.01%
1
-146
-99% -$11.3K
JACK icon
1064
Jack in the Box
JACK
$263M
$38 ﹤0.01%
4
-5,289
-100% -$93.5K
AURA icon
1065
Aura Biosciences
AURA
$745M
$36 ﹤0.01%
5
+1
+25% +$6
VIDI icon
1066
Vident International Equity Strategy
VIDI
$434M
$35 ﹤0.01%
1
NTST
1067
NETSTREIT Corp
NTST
$2.12B
$34 ﹤0.01%
2
-2,557
-100% -$49.2K
CLDX icon
1068
Celldex Therapeutics
CLDX
$2.78B
$32 ﹤0.01%
1
PBYI icon
1069
Puma Biotechnology
PBYI
$408M
$31 ﹤0.01%
5
CTMX icon
1070
CytomX Therapeutics
CTMX
$725M
$30 ﹤0.01%
6
-2
-25% -$10
PK icon
1071
Park Hotels & Resorts
PK
$2.94B
$30 ﹤0.01%
3
RKT icon
1072
Rocket Companies
RKT
$36.2B
$29 ﹤0.01%
2
DARE icon
1073
Dare Bioscience
DARE
$18.9M
$26 ﹤0.01%
14
+2
+17% +$3
RCUS icon
1074
Arcus Biosciences
RCUS
$3.74B
$26 ﹤0.01%
1
-1
-50% -$22
CRSP icon
1075
CRISPR Therapeutics
CRSP
$4.68B
$25 ﹤0.01%
1
-138
-99% -$7.28K

Similar funds

Inspire Investing's Q1 2026 Portfolio in Review

As of Q1 2026, Inspire Investing held 1,178 positions worth $1.71B, up 54% from $1.11B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Inspire Investing deployed $595M of net new capital in Q1 2026, opening 70 new positions and adding to 713 existing holdings. Its largest new stake was Fortinet: 106,964 shares worth $8.74M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Inspire International ETF, an estimated $3.23M trimmed.

  • Inspire Investing's largest Q1 2026 buy was Fortinet: 106,964 shares worth $8.74M.
  • Inspire Investing added most to Broadcom in Q1 2026, an estimated $74.6M increase.
  • Inspire Investing's biggest Q1 2026 reduction was Inspire International ETF, cutting an estimated $3.23M.
  • Inspire Investing fully exited BJs Wholesale Club in Q1 2026, selling an estimated $3.55M.
  • Inspire Investing's ten largest holdings make up 18% of its $1.71B portfolio in Q1 2026.
  • Inspire Investing opened 70 new positions and closed 70 in Q1 2026.
  • Inspire Investing's portfolio value rose 54% quarter-over-quarter to $1.71B.

Based on Inspire Investing's 13F filing for Q1 2026, filed 23 Apr 2026.